18
Analyze Genomes: Drug Response Analysis Dr. Matthieu-P. Schapranow Future Convention, Frankfurt, Germany Nov 23, 2015

Analyze Genomes: Drug Response Analysis

Embed Size (px)

Citation preview

Page 1: Analyze Genomes: Drug Response Analysis

Analyze Genomes: Drug Response Analysis

Dr. Matthieu-P. Schapranow Future Convention, Frankfurt, Germany

Nov 23, 2015

Page 2: Analyze Genomes: Drug Response Analysis

■  Since 2009 Program Manager E-Health & Life Sciences

■  2006-2014 Strategic Projects SAP HANA

■  Visiting Scientist at V.A., Boston, MA and Charité, Berlin

■  Ph.D. in Software Engineering

Whom you are dealing with?

Schapranow, Future Convention, 2015

Analyze Genomes: Drug Response Analysis

2

Page 3: Analyze Genomes: Drug Response Analysis

What is the Hasso Plattner Institute, Potsdam, Germany?

Schapranow, Future Convention, 2015

Analyze Genomes: Drug Response Analysis

3

Page 4: Analyze Genomes: Drug Response Analysis

Ind irect In te raction

D irect In te raction

C lin ic ian P atien tR esearcher

P harm aceu tica lC om pany

H ea lthcareP roviders

H osp ita lR esearch

C enterLabora to ry

P atien tA dvocacy

G roup

Intelligent Healthcare Networks in the 21st Century?

Schapranow, Future Convention, 2015

Analyze Genomes: Drug Response Analysis

4

Page 5: Analyze Genomes: Drug Response Analysis

Ind irect In te raction

D irect In te raction

C lin ic ian P atien tR esearcher

P harm aceu tica lC om pany

H ea lthcareP roviders

H osp ita lR esearch

C enterLabora to ry

P atien tA dvocacy

G roup

Intelligent Healthcare Networks in the 21st Century?

Schapranow, Future Convention, 2015

Analyze Genomes: Drug Response Analysis

5

Page 6: Analyze Genomes: Drug Response Analysis

Ind irect In te raction

D irect In te raction

C lin ic ian P atien tR esearcher

P harm aceu tica lC om pany

H ea lthcareP roviders

H osp ita lR esearch

C enterLabora to ry

P atien tA dvocacy

G roup

Intelligent Healthcare Networks in the 21st Century!

Schapranow, Future Convention, 2015

Analyze Genomes: Drug Response Analysis

6

Page 7: Analyze Genomes: Drug Response Analysis

IT Challenges in Life Sciences Distributed Heterogeneous Data Sources

Human genome/biological data >750GB per complete human genome >15PB in databases of leading institutes

Prescription data 1.5B records from 10,000 doctors and 10M Patients (100 GB)

Clinical trials >30k recruiting trials on ClinicalTrials.gov

Human proteome 160M data points (2.4GB) per sample >3TB raw proteome data in ProteomicsDB

PubMed database >24M unstructured data in publications

Hospital information systems >50GB structured relational data

Medical sensor data Scan of a single organ creates 10GB of raw data within 1s

Cancer patient records >160k records only at NCT

Analyze Genomes: Drug Response Analysis

Schapranow, Future Convention, 2015

7

Page 8: Analyze Genomes: Drug Response Analysis

■  Patient: 67 years, male, smoker, consumes frequently alcohol

■  Diagnosis: Squamous cell carcinoma of the oropharynx, T2N2bM0, stage IVa

1.  Surgery to remove tumor

2.  Tumor sample is sent to laboratory to extract DNA

3.  DNA is sequenced resulting in 750 GB of raw data per sample

4.  Processing of raw data to perform analysis

5.  Identification of relevant driver mutations using international medical knowledge

6.  Informed decision making

Use Case: Precision Medicine in Oncology Identification of Best Treatment Option for Cancer Patient

Schapranow, Future Convention, 2015

Analyze Genomes: Drug Response Analysis

8

Page 9: Analyze Genomes: Drug Response Analysis

Schapranow, Future Convention, 2015

Analyze Genomes: Drug Response Analysis

9

Page 10: Analyze Genomes: Drug Response Analysis

Schapranow, Future Convention, 2015

Analyze Genomes: Drug Response Analysis

10

Page 11: Analyze Genomes: Drug Response Analysis

Schapranow, Future Convention, 2015

we.analyzegenomes.com Real-time Analysis of Big Medical Data

11

In-Memory Database

Extensions for Life Sciences

Data Exchange, App Store

Access Control, Data Protection

Fair Use

Statistical Tools

Real-time Analysis

App-spanning User Profiles

Combined and Linked Data

Genome Data

Cellular Pathways

Genome Metadata

Research Publications

Pipeline and Analysis Models

Drugs and Interactions

Analyze Genomes: Drug Response Analysis

Drug Response Analysis

Pathway Topology Analysis

Medical Knowledge Cockpit Oncolyzer

Clinical Trial Recruitment

Cohort Analysis

...

Indexed Sources

Page 12: Analyze Genomes: Drug Response Analysis

Real-time Data Analysis and Interactive Exploration

Drug Response Analysis Data Sources

Schapranow, Future Convention, 2015

Analyze Genomes: Drug Response Analysis

Smoking status, tumor classification

and age (1MB - 100MB)

Raw DNA data and genetic variants

(100MB - 1TB)

Medication efficiency and wet lab results

(10MB - 1GB)

12

Patient-specific Data

Tumor-specific Data

Compound Interaction Data

Page 13: Analyze Genomes: Drug Response Analysis

Schapranow, Future Convention, 2015

Analyze Genomes: Drug Response Analysis

13

Page 14: Analyze Genomes: Drug Response Analysis

Showcase

Schapranow, Future Convention, 2015

Analyze Genomes: Drug Response Analysis

14 Calculating Drug Response… Predict Drug Response

Page 15: Analyze Genomes: Drug Response Analysis

Schapranow, Future Convention, 2015

Analyze Genomes: Drug Response Analysis

15

cetuximab might be more beneficial for the current case

Page 16: Analyze Genomes: Drug Response Analysis

■  Online: Visit we.analyzegenomes.com for latest research results, slides, videos, tools, and publications

■  Offline: Read more about it, e.g. High-Performance In-Memory Genome Data Analysis: How In-Memory Database Technology Accelerates Personalized Medicine, In-Memory Data Management Research, Springer,

ISBN: 978-3-319-03034-0, 2014

■  In Person: Join us for “Festival of Genomics” Jan 19-21, 2016 in London, UK

Where do you find additional information?

Schapranow, Future Convention, 2015

Analyze Genomes: Drug Response Analysis

16

Page 17: Analyze Genomes: Drug Response Analysis

■  Global Medical Knowledge (Master’s project)

■  Markers for cardiovascular diseases to

assess treatment options (DHZB)

■  Combine health data to improve health care research (AOK)

■  Pharmacogenetics (Bayer)

■  Generously supported by

Join us for upcoming projects!

Schapranow, Future Convention, 2015

Analyze Genomes: Drug Response Analysis

17

Interdisciplinary Design Thinking

Teams

You?

Page 18: Analyze Genomes: Drug Response Analysis

Keep in contact with us!

Hasso Plattner Institute Enterprise Platform & Integration Concepts (EPIC)

Program Manager E-Health August-Bebel-Str. 88

14482 Potsdam, Germany

Dr. Matthieu-P. Schapranow [email protected] http://we.analyzegenomes.com/

Schapranow, Future Convention, 2015

Analyze Genomes: Drug Response Analysis

18